These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30541577)

  • 21. Tobacco harm reduction: the need for new products that can compete with cigarettes.
    Fagerström KO; Bridgman K
    Addict Behav; 2014 Mar; 39(3):507-11. PubMed ID: 24290207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaping
    Rehan HS; Maini J; Hungin APS
    Curr Drug Saf; 2018; 13(2):92-101. PubMed ID: 29485005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
    Baldassarri SR; Bernstein SL; Chupp GL; Slade MD; Fucito LM; Toll BA
    Addict Behav; 2018 May; 80():1-5. PubMed ID: 29304395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' views on smoking cessation and tobacco harm reduction during drug treatment.
    Richter KP; McCool RM; Okuyemi KS; Mayo MS; Ahluwalia JS
    Nicotine Tob Res; 2002; 4 Suppl 2():S175-82. PubMed ID: 12573178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the nicotine content of combusted tobacco products sold in New Zealand.
    Donny EC; Walker N; Hatsukami D; Bullen C
    Tob Control; 2017 Mar; 26(e1):e37-e42. PubMed ID: 27672126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-cigarettes in patients with COPD: current perspectives.
    Morjaria JB; Mondati E; Polosa R
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3203-3210. PubMed ID: 29138548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Smoking cessation among HIV smokers: Experience of a French hospital-based smoking cessation service].
    Choulika S; Le Faou AL
    Encephale; 2017 Apr; 43(2):110-113. PubMed ID: 27339798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Workplace interventions for smoking cessation.
    Moher M; Hey K; Lancaster T
    Cochrane Database Syst Rev; 2003; (2):CD003440. PubMed ID: 12804467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphlet.
    Jolicoeur DG; Richter KP; Ahluwalia JS; Mosier MC; Resnicow K
    Subst Abus; 2003 Jun; 24(2):101-6. PubMed ID: 12766377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
    Kropp RY; Halpern-Felsher BL
    Pediatrics; 2004 Oct; 114(4):e445-51. PubMed ID: 15466070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community tobacco control leaders' perceptions of harm reduction.
    Joseph AM; Hennrikus D; Thoele MJ; Krueger R; Hatsukami D
    Tob Control; 2004 Jun; 13(2):108-13. PubMed ID: 15175521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Do more, smoke less!' Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit.
    Baker AL; Callister R; Kelly PJ; Kypri K
    Drug Alcohol Rev; 2012 Jul; 31(5):714-7. PubMed ID: 22519684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation.
    Warner KE; Mendez D
    Nicotine Tob Res; 2019 Jan; 21(1):41-47. PubMed ID: 29617887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The place for harm reduction and product regulation in UK tobacco control policy.
    Gilmore AB; Britton J; Arnott D; Ashcroft R; Jarvis MJ
    J Public Health (Oxf); 2009 Mar; 31(1):3-10. PubMed ID: 19109341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.